BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to HCC1954 cell line is 39
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CD44 | 1681 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | NA | Western Blotting | NA | 0.28 | 1 | 30139970 |
| CD44 | 1681 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | NA | FACs followed by SFA | NA | 0.28 | 1 | 35220209 |
| CD44 | 1681 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | MK-0752 | FACs | NA | 0.28 | 1 | 29027990 |
| CD44 | 1681 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | MK-0752 | FACs | NA | 0.28 | 1 | 29027990 |
| CD44 | 1681 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | NA | FACs followed by SFA | NA | 0.28 | 1 | 30326469 |
| CD44 | 1681 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | Lapatinib | SFA followed by FACs | NA | 0.28 | 1 | 29895705 |
| CD44 | 1681 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | Lapatinib | SFA followed by FACs | NA | 0.28 | 1 | 29895705 |
| KLF4 | 6348 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | NA | Western Blotting followed by SFA | NA | 0.28 | 0.0891 | 30326469 |
| MYC | 7553 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | NA | Western Blotting followed by SFA | NA | 0.28 | 0.1304 | 30326469 |
| MYC | 7553 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | Lapatinib | RT-PCR and SFA | NA | 0.28 | 0.1304 | 29895705 |
| MYC | 7553 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | Lapatinib | RT-PCR and SFA | NA | 0.28 | 0.1304 | 29895705 |
| POU5F1 | 9221 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | NA | Western Blotting followed by SFA | NA | 0.28 | 0.6448 | 30326469 |
| POU5F1 | 9221 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | MK-0752 | qRT-PCR | NA | 0.28 | 0.6448 | 29027990 |
| POU5F1 | 9221 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | MK-0752 | qRT-PCR | NA | 0.28 | 0.6448 | 29027990 |
| SOX2 | 11195 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | NA | Western Blotting followed by SFA | NA | 0.28 | 0.5695 | 30326469 |
| SOX2 | 11195 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | MK-0752 | qRT-PCR | NA | 0.28 | 0.5695 | 29027990 |
| SOX2 | 11195 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | MK-0752 | qRT-PCR | NA | 0.28 | 0.5695 | 29027990 |
| C5 | 1331 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | NA | FACs for CSC marker followed by IF staining | NA | 0.24 | 0.0021 | 35220209 |
| CCND1 | 1582 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | Lapatinib | RT-PCR and SFA | NA | 0.2 | 0.0201 | 29895705 |
| CCND1 | 1582 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | Lapatinib | RT-PCR and SFA | NA | 0.2 | 0.0201 | 29895705 |
| HEY2 | 4881 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | Lapatinib | RT-PCR and SFA | NA | 0.2 | 0.0021 | 29895705 |
| HEY2 | 4881 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | Lapatinib | RT-PCR and SFA | NA | 0.2 | 0.0021 | 29895705 |
| IL8 | 6025 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | NA | qRT-PCR followed by SFA | NA | 0.2 | 0.0159 | 19190339 |
| NANOG | 20857 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | MK-0752 | qRT-PCR | NA | 0.2 | 0.5461 | 29027990 |
| NANOG | 20857 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | MK-0752 | qRT-PCR | NA | 0.2 | 0.5461 | 29027990 |
| NOTCH1 | 7881 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | Lapatinib | RT-PCR and SFA | NA | 0.2 | 0.0477 | 29895705 |
| NOTCH1 | 7881 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | Lapatinib | RT-PCR and SFA | NA | 0.2 | 0.0477 | 29895705 |
| ALDH1A1 | 402 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | NA | ALDEFLUOR assay followed by SFA | NA | 0.12 | 0.684 | 35220209 |
| ALDH1A1 | 402 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | NA | ALDEFLUOR assay | NA | 0.12 | 0.684 | 19190339 |
| ALDH1A1 | 402 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | Lapatinib | ALDEFLUOR assay followed by SFA | NA | 0.12 | 0.684 | 29895705 |
| ALDH1A1 | 402 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | Lapatinib | ALDEFLUOR assay followed by SFA | NA | 0.12 | 0.684 | 29895705 |
| CD24 | 1645 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | NA | FACs followed by SFA | NA | 0.12 | 0.456 | 35220209 |
| CD24 | 1645 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | MK-0752 | FACs | NA | 0.12 | 0.456 | 29027990 |
| CD24 | 1645 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | MK-0752 | FACs | NA | 0.12 | 0.456 | 29027990 |
| CD24 | 1645 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | NA | FACs followed by SFA | NA | 0.12 | 0.456 | 30326469 |
| CD24 | 1645 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | Lapatinib | SFA followed by FACs | NA | 0.12 | 0.456 | 29895705 |
| CD24 | 1645 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | Lapatinib | SFA followed by FACs | NA | 0.12 | 0.456 | 29895705 |
| JAG1 | 6188 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | Lapatinib | FACs followed by SFA | NA | 0.12 | 0.0117 | 29895705 |
| JAG1 | 6188 | LTM | HER2 Positive Breast Cancer | Ductal Carcinoma | HCC1954 | Lapatinib | FACs followed by SFA | NA | 0.12 | 0.0117 | 29895705 |